Heat-shock protein 60 and cardiovascular disease: A paradoxical role

Future Cardiology

Volumn 4, Issue 2, 2008, Pages 151-161

  Knowlton, Anne A ^a,b   Srivatsa, Uma ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibodies; Atherosclerosis; Atrial fibrillation; Autoimmunity; Diabetes; Heart failure; HSP60; Innate immunity; Serum

Indexed keywords

BACTERIAL PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 65; PROTEIN ANTIBODY;

APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CORONARY ARTERY DISEASE; CYTOSOL; DISEASE MARKER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; INFLAMMATION; INNATE IMMUNITY; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW;

EID: 40649106751     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/14796678.4.2.151     Document Type: Review

References (82)

1. Ali A, Bharadwaj S, O'Carroll R, Ovsenek N: HSP90 interacts with and regulates the activity of heat shock factor 1 in Xenopus oocytes. Mol. Cell. Biol. 18, 4949-4960 (1998).
2. Aligue R, Akhavan-Niak H, Russell P: A role for HSP 90 in cell cycle control: Wee 1 tyrosine kinase activity requires interaction with HSP 90. EMBO 13, 6099-6106 (1994).
3. Pratt WB: The HSP90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors. Proc. Soc. Exp. Biol. Med. 217, 420-434 (1998).
4. Hartson SD, Matts RL: Association of HSP 90 with cellular Src-family kinases in a cell-free system correlates with altered kinase structure and function. Biochemistry 33, 8912-8920 (1994).
5. Kirby LB, Mondy JS, Brophy CM: Balloon angioplasty induces heat shock protein 70 in human blood vessels. Ann. Vasc. Surg. 13, 475-479 (1999).
6. Knowlton AA, Brecher P, Apstein CS: Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J. Clin. Invest. 87, 139-147 (1991).
7. Mehta HB, Popovich BK, Dillmann WH: Ischemia induces changes in the level of mRNAs coding for stress protein 71 and creatine kinase M. Circ. Res. 63, 512-517 (1988).
8. Nakano M, Mann DL, Knowlton AA: Blocking the endogenous increase in HSP72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes. Circulation 95, 1523-1531 (1997).
9. Kirchhoff SR, Gupta S, Knowlton AA: Cytosolic HSP60, apoptosis, and myocardial injury. Circulation 105, 2899-2904 (2002).
10. Hutter JJ, Mestril R, Tam EKW, Sievers RE, Dillmann WH, Wolfe CL: Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation 94, 1408-1411 (1996).
11. Plumier JCL, Ross BM, Currie RW et al.: Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J. Clin. Invest. 95, 1854-1860 (1995).
12. Lau S, Patnaik N, Sayen MR, Mestril R: Simultaneous overexpression of two stress proteins in rat cardiomyocytes and myogenic cells confers protection against ischemia-induced injury. Circulation 96, 2287-2294 (1997).
13. Lin KM, Lin B, Lian IY, Mestril R, Scheffler I, Dillmann WH: Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation 103, 1787-1792 (2001).
14. Bender AT, Silverstein AM, Demady DR et al.: Neuronal nitric-oxide synthase is regulated by the HSP90-based chaperone system in vivo. J Biol. Chem. 274, 1472-1478 (1999).
15. Shah V, Wiest R, Garcia-Cardena G, Cadelina G, Grozmann RJ, Sessa WC: HSP90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am. J. Physiol. 277, g463-g468 (1999).
16. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, Bender J: Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J. Biol. Chem. 275, 5026-5030 (2000).
17. Soltys BJ, Gupta RS: Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (HSP60) in mammalian cells. Exp. Cell Res. 222, 16-27 (1996).
18. Lin L, Kim SC, Wang Y et al.: HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am. J. Physiol. 293, H2238-H2247 (2007).
19. Ellis R: The Chaperanins. Academic Press, NY, USA (1996).
20. Shan YX, Liu TJ, Su HF, Samsamshariat A, Mestril R, Wang PH: HSP10 and HSP60 modulate BCL-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J. Mol. Cell. Cardiol. 35, 1135-1143 (2003).
21. Veres A, Szamosi T, Abionczy M et al.: Complement activating antibodies against the human 60 kDa heat shock protein as an independent family risk factor of coronary heart disease. Eur. J. Clin. Invest. 32, 405-410 (2002).
22. Gupta S, Knowlton AA: Cytosolic HSP60, hypoxia and apoptosis. Circulation 106, 2727-2733 (2002).
23. Gupta S, Knowlton AA: HSP60, BAX, apoptosis and the heart. J. Cell. Mol. Med. 9, 51-58 (2005).
24. Gupta S, Knowlton AA: HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am. J. Physiol. Heart Circ. Physiol. 292, H3052-H3056 (2007).
25. Knowlton AA, Kapadia S, Torre-Amione G et al.: Differential expression of heat shock proteins in normal and failing human hearts. J. Mol. Cell. Cardiol. 30, 811-818 (1998).
26. Latif N, Taylor PM, Khan MA, Yacoub MH, Dunn MJ: The expression of heat shock protein 60 in patients with dilated cardiomyopathy. Basic Res. Cardiol. 94, 112-119 (1999).
27. Tanonaka K, Furuhama KI, Yoshida H et al.: Protective effect of heat shock protein 72 on contractile function in the perfused failing heart. Am. J. Physiol. 281, H215-H222 (2001).
28. Fiszer-Kierzkowska A, Wysocka A, Jarzab M, Lisowska K, Krawczyk Z: Structure of gene flanking regions and functional analysis of sequences upstream of the rat HSP70. 1 stress gene. Biochim. Biophys. Acta 1625, 77-87 (2003).
29. Chen H, Shan YX, Yang TL, Lin H, Chen J, Lin SJ: Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes54, 175-181 (2005).
30. Lai HC, Liu TJ, Ting CT et al.: Regulation of IGF-I receptor signaling in diabetic cardiac muscle: dysregulation of cytosolic and mitochondria HSP60. Am. J. Physiol. Endocrinol. Metab. 292, E292-E297 (2007).
31. Schäfler A, Kirmanoglou K, Pecher P, Hannekum A, Schumacher B: Overexpression of heat shock protein 60/10 in myocardium of patients with chronic atrial fibrillation. Ann. Thorac. Surg. 74, 767-770 (2002).
32. Yang M, Tan H, Cheng L et al.: Expression of heat shock proteins in myocardium of patients with atrial fibrillation. Cell Stress Chaperones 12, 142-150 (2007).
33. Mandal K, Jahangiri M, Mukhin M, Poloniecki J, Camm AJ, Xu Q: Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation. Circulation 110, 2588-2590 (2004).
34. Oc M, Ucar H, Pinar A et al.: Heat shock protein 60 antibody. A new marker for subsequent atilal fibrillation development. Saudi Med. J. 28, 844-847 (2007).
35. Hochleitner BW, Hochleitner EO, Obrist P et al.: Fluid shear stress induces heat shock protein 60 expression in enclothelial cells in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 20, 617-623 (2000).
36. Issac TT, Dokainish H, Lakkis NM: Role of inflammation in initiation and perpetuation of atrial fibrillation. J. Am. Coll. Cardiol. 50, 2021-2028 (2007).
37. Ohashi K, Burkart V, Flohe S, Kolb H: Cutting edge: heat shock protein 60 is a putative enclogenous ligand of the Toll-like receptor-4 complex. J. Immunol. 164, 558-561 (2000).
38. Carroll M: Innate immunity in the etiopathology of autoinimunity. Nat. Immunol. 2, 1089-1090 (2001).
39. de Graaf R, Kloppenburg G, Kitslaar PJHM, Bruggeman CA, Stassen F: Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toil-like receptors 2 and 4. Micrabes Infect. 8, 1859-1865 (2006).
40. Hollestelle SCG, de Vries MR, van Keulen JK et al.: Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 109, 393-839 (2004).
41. Schoneveld AH, Hoefer I, Sluijter JPG, Laman J, de Kleijn D, Pasterkamp G: Atherosclerotic lesion development and Toll-like receptor 2 and 4 responsiveness. Atherosclerosis (2008) (In Press).
42. de Graeff-Meeder E, Rijkers G, Voorhorst-Ogink M et al.: Antibodies to human HSP60 in patients with juvenile chronic arthritis, diabetes mellitus, and cystic fibrosis. Pediatr. Res. 34, 424-428 (1993).
43. de Graeff-Meeder E, Van der Zee R, Rijkers G et al.: Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 8754, 1368-1372 (1991).
44. Pope R, Lovis R, Gupta RS: Activation of synovial fluid T lymphocytes by 60-kd heatshock proteins in patients with inflammatory synovitis. Arthritis Rheum. 35, 43-48 (1992).
45. Res P, Schaar C, Breedveld F et al.: Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 2, 478-480 (1988).
46. Boog C, de Graeff-Meeder E, Lucassen M et al.: Two monoclonal antibodies generated against human HSP60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J. Exp. Med. 175, 1805-1810 (1992).
47. Jamin C, Dugúe C, Alard JE et al.: Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to HSP60 in vasculitis-associated systemic autoimmune disease. Arthritis Rheum. 52, 4028-4038 (2005).
48. Dieude M, Sencecal JL, Raymond Y: Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial call autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum. 50, 3221-3231 (2004).
49. Alard JE, Dueymes M, Youinou P, Jamin C: Modulation of endothelial cell damages by anti-HSP60 autoantibodies in systemic autoimmune diseases. Autoimmun. Rev. 6, 438-443 (2007).
50. Wick G, Knoflach M, Xu Q: Autoimmune and inflammatory mechanisms in atherosclerosis. Annu. Rev. Immunol. 22, 361-403 (2004).
51. Kiechl S, Egger G, Mayr M et al.: Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 103, 1064-1070 (2001).
52. Schattner A, Rager-Zisman B: Virus induced autoimmunity. Rev. Infect. Dis. 12, 204-222 (1990).
53. Chen W, Syldath U, Bellmann K, Burkart V, Kolb H: Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J. Immunol. 162, 3212-3219 (1999).
54. Wallin R, Lundgvist A, Moré S, von Bonin A, Kiessling R, Ljunggren H: Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23, 130-135 (2002).
55. Tsan MF, Gao B: Cytokine function of heat shock proteins. Am. J. Physiol. Cell Physiol. 286, C739-C744 (2004).
56. Xu Q, Dietrich H, Steiner HJ et al.: Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler. Thromb. Vasc. Biol. 12, 789-799 (1992).
57. Foteinos G, Afzal AR, Mandall K, Jahangiri M, Xu Q: Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation 112, 1206-1213 (2005).
58. George J, Afek A, Gilburd B, Shoenfeld Y, Harats D: Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J. Am. Coll. Cardiol. 38, 900-905 (2001).
59. Shoenfeld Y, Harats D, George J: Heat shock protein 60/65, b2-glycoprotein I and oxidized LDL as players in murine atherosclerosis. J. Autoimmun. 15, 199-202 (2000).
60. Xu Q, Willems JL, Marosi M et al.: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet 341, 255-259 (1993).
61. Xu Q, Kiechi S, Mayr M et al.: Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study. Circulation 100, 1169-1174 (1999).
62. Knoflach M, Kiechi S, Kind M et al.: Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation 108, 1064-1069 (2003).
63. Knoflach M, Kiechi S, Mayri B et al.: T-cell reactivity against HSP60 relates to early but not advanced atherosclerosis. Atherosclerosis 195, 333-338 (2007).
64. Soltys BJ, Gupta RS: Cell surface localization of the 60 kDa heat shock chaperonin protein (HSP60) in mammalian cells. Cell Biol. Int. Rep. 21, 315-320 (1997).
65. Pockley AG, Bulmer J, Hanks B, Wright B: Identification of human heat shock protein 60 (HSP60) and anti-HSP60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones 4, 29-35 (1999).
66. Shamaei-Tousi A, D'Aiuto F, Niball L et al.: Differential regulation of circulating levels of molecular chaperones in patients undergoing treatment for periodontal disease. PLoS One 2, e1198 (2007).
67. Shamaei-Tousi A, Steptoe A, O'Donnell K et al.: Plasma heat shock protein 60 and cardiovascular disease risk: the role of psychosocial, genetic and biological factors. Cell Stress Chaperones 12, 384-392 (2007).
68. Singh B, Patel HV, Ridley RG, Freeman KB, Gupta RS: Mitochondrial import of the human chaperonin (HSP60) protein. Biochem. Biophys. Res. Commun. 169, 391-396 (1990).
69. Pockley AG, Wu R, Lemne C, Kiessling R, de Faire U, Frostegard J: Circulating heat shock protein 60 is amociated with early cardiovascular disease. Hypertension 36, 303-307 (2000).
70. Pockley AG, de Faire U, Kiessling R, Lemne C, Thulin T, Frostegard J: Circulating heat shock protein and heat shock protein antibody levels in established hypertension. J. Hypertens. 20, 1815-1820 (2002).
71. Xu Q, Schett G, Perschinka H et al.: Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102, 14-20 (2000).
72. Xiao Q, Mandal K, Schett G et al.: Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical Significance determined in a follow-up study. Stroke 36, 2571-2576 (2005).
73. Wright B, Corton J, El-Nahas A, Wood R, Pockley A: Elevated levels of circulating heat shock protein 70 (HSP70) in peripheral and renal vascular disease. Heart Vessels 15, 18-22 (2000).
74. Shamaei-Tousi A, Stephens JW, Bin R et al.: Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur. Heart J. 27, 1565-1570 (2006).
75. Anand SS, Yusuf S, VuksannV et al.: Differences in risk factors, atherosclerosis and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic Groups (SHARE). Lancet 353, 279-284 (2000).
76. Giannessi D, Caselli C, Vitale RL et al.: A possible cardioprotective effect of heat shock proteins during cardiac surgery in pediatric patients. Pharmacol. Res. 48, 519-529 (2003).
77. Anderson JL, Muhlestein JB: Antibiotic trials for coronary artery disease. Tex. Heart Inst. J. 31, 33-38 (2004).
78. Anderson JL, Muhlestein JB, Carlquist J et al.: Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. Circulation 99, 1540-1547 (1999).
79. Schett G, Metzler B, Kleindienst R et al.: Myocardial injury leads to a release of heat shock protein (HSP) 60 and a suppression of the anti-HSP65 immune response. Cardiovasc. Res. 42, 685-695 (1999).
80. Mason R, Sukhova G, Faria AM et al.: Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation 106, 1708-1715 (2002).
81. van Puijvelde GHM, van Es T, van Wanrooij EJA et al.: Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 2677-2683 (2007).
82. Harats D, Yacav N, Gilburd B, Shoenfeld Y, George J: Oral tolerance with heat shock protein 65 attenuates mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll. Cardiol. 40, 1333-1338 (2002).